Sjogren`s Syndrome, Alessia, Alunno

Scientific progress has allowed us to unmask novel pathogenic mechanisms, to perform genome wide studies, and to identify clinical and serological features associated with different disease subsets and, eventually, different disease prognoses. In addition, the increasing knowledge about SS pathogenesis provides the rationale to employ targeted therapies in SS as has already occurred in rheumatoid arthritis and systemic lupus erythematosus.
Discusses heterogeneity of topics and audience, from basic immunology to clinical aspects and therapeuticsProvides novel lines of investigation and supports the management of patients requiring novel therapeutic approachesPresents a deeper knowledge on SS clinical management as well as on immunological aspects possibly leading to new lines of investigationOffers a bridge between the clinician and the scientist, and vice versaProvides the reader with most recent and relevant updates due to the novelty of topics